Spazam koronarne arterije – jedan medicinski entitet sa različitim terapijskim opcijama

  • Vladimir Zdravković University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
  • Rada Vučić University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
  • Miodrag Srećković University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
  • Ivan Simić University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
  • Vojislav Mitrović Klinikum Coburg, GmbH, Department of Cardiology, Coburg, Germany
  • Dragan Dinčić Military Medical Academy, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Slavko Knežević Clinical Center Kragujevac, Department of Internal Medicine, Kragujevac, Serbia
  • Nemanja Zdravković University of Kragujevac, Faculty of Medical Sciences, Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
Ključne reči: infartk miokarda;, aa.coronariae, spazam;, lečenje;, verapamil;, angioplastika, tanslumenska, perkutana, koronarna.

Sažetak


Apstrakt

 

Uvod. Infarkt miokarda se karakteriše kritičnom ishemijom miokarda praćenom ireverzibilnim oštećenjem ili smrću ćelija. Prikazi bolesnika. Prikazali smo dva slična klinička slučaja bolesnika sa dijagnozom infarkta miokarda sa elevacijom ST segmenta (STEMI), oba sa vazospazmom koronarnih arterija, ali sa različitim terapijskim pristupom, zbog različitih osnovnih patofizioloških supstrata i kliničkih prezentacija. Zaključak. Spazam koronarne arterije je veoma kompleksan patofiziološki entitet, sa različitim terapijskim opcijama. Iako perkutana koronarna intervencija može biti prvi izbor, strategija lečenja ipak treba da bude pažljivo isplanirana.

Biografija autora

Rada Vučić, University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia

Department of cardiology - interventional cardiologist

Faculty of medical sciences  - assistant

Reference

REFERENCES

Thygesen K, Alpert JS, White HD. Universal Definition of Myo-cardial Infarction. J Am Coll Cardiol 2007; 50(22): 2173‒95.

Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome. The CASPAR (Coronary Ar¬tery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol 2008; 52(7): 523‒7.

Lanza GA, Carreri G, Crea F. Mechanisms of Coronary Ar¬tery Spasm. Circulation 2011; 124(16): 1774‒82.

Wang LX, Lü SZ, Zhang WJ, Song XT, Chen H, Zhang LJ. Cor-onary spasm, a pathogenic trigger of vulnerable plaque rup-ture. Chin Med J 2011; 124(23): 4071‒8.

Steg G, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33(20): 2569‒619.

Giacoppo D, Baber U, Mehran R. Current developments in dual antiplatelet therapy after stenting. Minerva Cardioan¬giologica 2014; 62(3): 261‒76.

Kaneda H, Taguchi J, Kuwada Y, Hangaishi, Aizawa T, Ya¬makado M, et al. Coronary artery spasm and the polymor¬phisms of the endothelial nitric oxide synthase gene. Circ J 2006; 70(4): 409–13.

Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fu-kata Y, et al. Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary ar¬tery spasm in a por-cine model with interleukin-1beta. Cir¬culation 2000; 101(11): 1319–23.

Otsuka F, Sakakura S, Virmani R. Are mast cells the real cul-prit in atherosclerosis? Eur Heart J 2013; 34(48): 3681‒3.

Zdravkovic V, Pantovic S, Rosic G, Tomic Lucic A, Zdravk¬ovic N, Colic M, et al. Histamine Blood Concentration in Ischemic Heart Disease Patients. J Biomed Biotechnol 2011; 2011: 315709.

Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 2000; 118(6): 1690‒5.

Objavljeno
2020/12/08
Rubrika
Prikaz bolesnika